$83.9 Million is the total value of Davide Leone & Partners Investment Co Ltd.'s 4 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 166.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
FIS | New | FIDELITY NATL INFORMATION SV | $36,118,584 | – | 664,800 | +100.0% | 43.05% | – |
SGEN | New | SEAGEN INC | $30,572,970 | – | 151,000 | +100.0% | 36.44% | – |
FCNCA | New | FIRST CTZNS BANCSHARES INC Ncl a | $16,737,320 | – | 17,200 | +100.0% | 19.95% | – |
BRKA | BERKSHIRE HATHAWAY INC DELcl a | $465,600 | -0.7% | 1 | 0.0% | 0.56% | +124.7% | |
FHN | Exit | FIRST HORIZON CORPORATION | $0 | – | -1,418,103 | -100.0% | -18.32% | – |
QQQ | Exit | INVESCO QQQ TRcall | $0 | – | -580,000 | -100.0% | -81.43% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BERKSHIRE HATHAWAY INC DEL | 19 | Q3 2023 | 7.8% |
ACADIA HEALTHCARE COMPANY IN | 9 | Q4 2021 | 14.1% |
BLACKBERRY LTD | 9 | Q4 2021 | 10.1% |
ILLUMINA INC | 8 | Q4 2020 | 8.8% |
ENCOMPASS HEALTH CORP | 7 | Q2 2022 | 98.2% |
INCYTE CORP | 6 | Q1 2021 | 5.0% |
AMERICAN WELL CORP | 6 | Q4 2021 | 2.7% |
BIOMARIN PHARMACEUTICAL INC | 5 | Q3 2021 | 9.1% |
VONTIER CORPORATION | 5 | Q4 2021 | 9.9% |
QIAGEN NV | 5 | Q1 2021 | 7.7% |
View Davide Leone & Partners Investment Co Ltd.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR/A | 2021-11-16 |
View Davide Leone & Partners Investment Co Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.